CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation
Quteineh L, Eap C, Pascual M, Soccal P, Dufour J, Mohacsi P, Steiger J, van Delden C, Binet F, Mueller N, Lehmann R, Treyer A, Kutalik Z, Manuel O, Venetz J, Crettol S, Golshayan D, Bochud P, and The Swiss Transplant Cohort Study. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics J 2015; 17:69-75.
08.12.2015
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation
08.12.2015
Pharmacogenomics J 2015; 17:69-75
Quteineh L, Eap C B, Pascual M, Soccal P M, Dufour J-F, Mohacsi P, Steiger J, van Delden C, Binet Françoise-Isabelle, Mueller N J, Lehmann R, Treyer A, Kutalik Z, Manuel O, Venetz J-P, Crettol S, Golshayan D, Bochud P-Y, and The Swiss Transplant Cohort Study
Weiter
